ZYDUS LIFESCIENCES Q1 UPDATE
Stock market update: Nifty Pharma index advances 0.65%
The Nifty Pharma index closed 0.65 per cent up at 19915.3.
Stock market update: Nifty Pharma index advances 0.64% in an upbeat market
The Nifty Pharma index was trading 0.64 per cent up at 19913.35.
Stock market update: Nifty Pharma index advances 0.14%
The Nifty Pharma index closed 0.14 per cent up at 19786.4.
Stock market update: Nifty Pharma index advances 0.14%
The Nifty Pharma index closed 0.14 per cent up at 19758.25.
Stock market update: Nifty Pharma index advances 0.16% in an upbeat market
The Nifty Pharma index was trading 0.16 per cent up at 19762.5.
Stock market update: Nifty Pharma index advances 0.1% in an upbeat market
The Nifty Pharma index was trading 0.1 per cent up at 19541.55.
- Go To Page 1
Q4 results: Stable costs boost India Inc. profits
Steady costs and firm domestic demand supported corporate performance in the March quarter.
Stock market update: Nifty Pharma index advances 1.0%
The Nifty Pharma index closed 1.0 per cent up at 19774.7.
Stock market update: Nifty Pharma index falls 1.56% in an upbeat market
The Nifty Pharma index was trading 1.56 per cent down at 19015.55.
Eris Lifesciences Q4 Results: Net profit jumps over 29% to Rs 80 crore
The Ahmedabad-based drug maker reported a net profit of Rs 61.5 crore during the corresponding quarter of the previous year. Revenue of Q4FY 24 grew by 37% YoY to Rs 551 crore. The net debt on March 31 stood at Rs 2700 crore.
Zydus Lifesciences Q4 Results: Drug makers posts threefold YoY jump in net profit to Rs 1,182 crore
Zydus Lifesciences on Friday reported Rs 1,182 crore net profit in Q4FY24, a threefold year-on-year (YoY) jump led by growth in US, India, Europe and emerging market sales.
Zydus Q4 Results: Net profit surges 4-fold to Rs 1,182 crore; revenue at Rs 5,534 cr
Zydus Lifesciences on Friday said its consolidated net profit surged four-fold to Rs 1,182 crore for the fourth quarter ended March 31, 2024 on higher sales. The drug firm had reported a net profit of Rs 297 crore in the January-March quarter of the 2022-23 fiscal.
Stock market update: Nifty Pharma index falls 1.86%
The Nifty Pharma index closed 1.86 per cent down at 18846.3.
Stock market update: Nifty Pharma index advances 1.57%
The Nifty Pharma index closed 1.57 per cent up at 18878.15.
Stock market update: Nifty Pharma index advances 1.3%
The Nifty Pharma index closed 1.3 per cent up at 18643.0.
Stock market update: Nifty Pharma index falls 1.72%
The Nifty Pharma index closed 1.72 per cent down at 18788.65.
Zydus Lifesciences net profit jumps 27% in Q3FY24, announced buyback
Zydus Lifesciences on Tuesday reported Rs 789.6 crore net profit in Q3FY24, a year-on-year (YoY) jump of 27% led by growth in India, Europe and emerging market formulation sales.
Zydus Lifesciences Q3 Results: Firm beats profit estimates; approves shares buyback
Indian generic drugmaker Zydus Lifesciences reported a bigger-than-expected rise in third-quarter profit on Friday, driven by strong sales in its domestic and overseas markets.
Good for all market conditions: 6 largecap stocks with right mix of RoE & RoCE
There is sunshine all around, better than expected GDP numbers, further decline in oil prices, falling US bond yields and clear indication from RBI that it is in no mood to increase interest rates any further. So while macros are bullish and could not get better, it is time to spend some time in understanding what stocks are you buying and why that stock at this point of time only. Also if one is thinking about increasing the exposure it would be better to stay with large caps as they would be able to weather any storm which might emerge due to any reason.
Glenmark Pharma Q2 Results: Co posts loss on exceptional legal costs
The company posted a consolidated net loss, from continuing operations, of 2.01 billion rupees ($24.14 million) for the three months ended Sept. 30, from a profit of 1.54 billion rupees a year ago
Zydus Lifesciences Q2 Results: Firm reports 53% YoY jump in net profit at Rs 801 crore
Revenue from operations rose 9.1% YoY to Rs 4369 crore in Q2FY24 compared to Rs 4006 crore in Q2FY23. On QoQ revenue declined 15%. The earnings before interest, tax, depreciation and ammortisation (EBITDA) increased 40.6% YoY to Rs 1146 crore. On QoQ, EBITDA dropped 23.9%.
Zydus Q2 Results: Profit jumps on strong domestic, US demand
India's generic drug makers, which draw a significant share of revenue from the crucial U.S. market, are recovering from the effects of eroding prices in the largest drug market in the world.
Zydus Lifesciences Q1 Results: Net profit doubles to Rs 1,087 crore, revenue jumps 30%
US business grew by 57% YoY at Rs 2454 crores. India branded formulations grew by almost 12%, excluding impact of NLEM related price cut affecting some key products
Zydus Lifesciences Q1 Results: Profit more than doubles on US sales growth
Its U.S formulations business saw a revenue growth of 57.4% to 24.54 billion rupees, while India formulations grew by 9.1% to 12.27 billion rupees. India and U.S. sales make up 38% and 48% of Zydus' total revenue, respectively.
Q1 results this week: LIC, Adani Ports, IRCTC, Hero MotoCorp, Nykaa and others
Adani Ports, Coal India, Siemens, Hindalco, Linde India, Lloyds Metals, Phoenix Mills, Oil India, Prestige Estates, Aarti Industries, Happiest Minds, Brigade Enterprises, Suven Pharma, Eureka Forbes and others will announce their June quarter results
Q1 earnings: 26 companies that may report over 100% jump in profit
Domestic brokerage Motilal expects Nifty earnings to grow 25% YoY in Q1. Oil and gas sector may report a 3x surge in profit YoY underpinned by the improvement in marketing margins of OMCs. Auto sector’s earnings may surge 11x YoY during the quarter on a low base.
Stock market update: Nifty Pharma index advances 1.06%
The Nifty Pharma index closed 1.06 per cent up at 12812.8.
Stock market update: Nifty Pharma index advances 1.03%
The Nifty Pharma index closed 1.03 per cent up at 12440.45.
Stock market update: Nifty Pharma index falls 1.27%
The Nifty Pharma index closed 1.27 per cent down at 12241.35.
Load More
